rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert R. Ruffolo

Director

Company insider

Files Form 4 as: Director, Elicio Therapeutics; Director, LB Pharmaceuticals; Director, Sigilon Therapeutics; Director, Aridis Pharmaceuticals; Director, CervoMed; Sr. VP & Pres., Wyeth Research, Wyeth.

Every Form 4 they filed

In numbers

Trades disclosed
57
Buys
0
Sells
4
Bought
$0
Sold
$15.5M
Companies
6
Companies where not an officer
5
First trade
27 Jan 2006
Last trade
31 Aug 2026
Last filed
2 Sep 2026

Companies traded

Where they are an officer
WyethOfficer · last 29 Feb 20080 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ELTX Elicio TherapeuticsDirector · Biotechnology · last 31 Aug 20260 buys · 0 sells
LBRX LB PharmaceuticalsDirector · Biotechnology · last 3 Jun 20260 buys · 0 sells
Sigilon TherapeuticsDirector · last 11 Aug 20230 buys · 1 sell
Aridis PharmaceuticalsDirector · last 5 Dec 20220 buys · 0 sells
CRVO CervoMedDirector · Biotechnology · last 14 Jun 20180 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Aug 2026filed 2 Sep 2026ELTX Elicio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—21,750 at $0.00filing
31 Aug 2026filed 2 Sep 2026ELTX Elicio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—21,750 at $0.00filing
3 Jun 2026filed 5 Jun 2026LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
3 Jun 2026filed 5 Jun 2026LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—1,792filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—1,792filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—717filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—717filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code D—10,757filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—10,757filing
10 Sep 2025filed 12 Sep 2025LBRX LB Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—22,449 at $0.00filing
19 May 2025filed 20 May 2025ELTX Elicio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—7,900 at $0.00filing
21 Nov 2024filed 25 Nov 2024ELTX Elicio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—4,100 at $0.00filing
28 Dec 2023filed 29 Dec 2023ELTX Elicio Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—4,100 at $0.00filing
11 Aug 2023filed 11 Aug 2023Sigilon Therapeuticsoption or derivativeSEC FORM 4 Code D$4,535683 at $6.64filing
11 Aug 2023filed 11 Aug 2023Sigilon Therapeuticsoption or derivativeSEC FORM 4 Code D$3,415683 at $5.00filing
11 Aug 2023filed 11 Aug 2023Sigilon Therapeuticsoption or derivativeSEC FORM 4 Code D$28K3,754 at $7.51filing
19 May 2023filed 22 May 2023Sigilon Therapeuticsoption or derivativeSEC FORM 4 Code A—8,888 at $0.00filing
5 Dec 2022filed 7 Dec 2022Aridis Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—10,000 at $0.00filing
26 May 2022filed 27 May 2022Sigilon Therapeuticsoption or derivativeSEC FORM 4 Code A—8,888 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed4

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.